Genital Diseases, Female  >>  sirolimus  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sirolimus / Generic mfg.
NCT01031381: Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer

Checkmark ASCO 2016
May 2016 - May 2016: ASCO 2016
Completed
2
50
US
RAD001, everolimus, derivative of rapamycin, bevacizumab, Avastin
University of Pittsburgh, Novartis Pharmaceuticals, Genentech, Inc.
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
01/14
12/14

Download Options